Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-18, Stock:NVO, The news for the past five days is as follows:
2021-11-11: NEWS1: European Authorities Recommend Approval Of Wegovy For Obesity.NEWS2: Wegovy™ recommended for approval for the treatment of obesity by the European regulatory authorities.
2021-11-12: NEWS1: Novo Nordisk (NVO) Gets Positive CHMP Opinion for Wegovy.NEWS2: EMA Backs Approval Of Novo Nordisk's Ozempic 2mg Dose For Diabetes.NEWS3: The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares.NEWS4: Ozempic® 2.0 mg recommended for approval for the treatment of type 2 diabetes by the European Medicines Agency.
2021-11-15: NEWS1: Ascendis (ASND) Gets Positive CHMP Opinion for GHD Drug Filing.NEWS2: Novo Nordisk A/S – Share repurchase programme.
2021-11-16: NEWS1: Top Research Reports for Adobe, Novo Nordisk & Qualcomm.
2021-11-17: NEWS1: The Zacks Analyst Blog Highlights: Adobe, Novo Nordisk, Qualcomm, Boeing, and Uber.NEWS2: GSK or NVO: Which Is the Better Value Stock Right Now?.NEWS3: 3 Big Pharma Outperformers to Watch Out For in the Near Term.

Answer: Rise